Spectranetics (SPNC): Any info? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Spectranetics (SPNC): Any info?

SPNC 38.45

0.0%

Aug 10 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

From: Glenn Petersen	12/3/2005 8:49:41 AM
	of 60

This week's issue of Business Week has a small article by Gene Marcial on SPNC. While the stock has had a nice run, it appears to be a bit pricey based on the EPS estimate of $.14 per share for 2007. Why Spectranetics Is Special Tiny medical device maker Spectranetics (SPNC) has been a stock on the go, climbing since May from 5 to 11. Its devices are used to treat coronary artery ailments. Its CVX-300(R) laser is the only Food & Drug Administration-approved system for removing plaque and clots in blood vessels. In April, Spectranetics won FDA approval to use the laser for removing blockages in leg arteries. The company's laser is gaining "significant attention in the medical community," says Suraj Kalia of investment firm Rodman & Renshaw, who tags the stock "outperform," with a target of 14. Occlusions in arm and leg arteries will be a large market for Spectranetics, says Matt Duncan of investment firm Stephens. He expects earnings to jump from 3 cents a share on sales of $55 million in 2006 to 14 cents in 2007 on $68 million. Elizabeth Jones of Kornitzer Capital Management, which owns stock, says the volume of laser procedures are on the rise and puts Spectranetics in a "sweet spot" in a fast-growing market. Advertisement Note: Unless otherwise noted, neither the sources cited in Inside Wall Street nor their firms hold positions in the stocks under discussion. Similarly, they have no investment banking or other financial relationships with them. businessweek.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext